Sun et al. reported the advantage of detecting CTC level via EpCAM magnetic bead-based enrichment combined with cytometric identification over serum carcinoembryonic antigen (CEA) for predicting treatment responses in rectal cancer [24], finding a close correlation between CTC levels and treatment outcomes [24]. Here, CEACAM5 is linked to rectal cancer.